Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Scientific News Boston Scientific Sees Success In Pfa Device Trial

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Sees Success In Pfa Device Trial is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Scientific News Boston Scientific Sees Success In Pfa Device Trial | RobinsPost News & Noticias

Boston Scientific’s FARAPULSE PFA: Revolutionizing Cardiac Ablation


Boston Scientific’s FARAPULSE Pulsed Field Ablation (PFA) system is making waves in how doctors treat irregular heart ... Read More

Boston Scientific enrolls first patient in AFib mapping study using OptiMap, Farapulse


A Boston Scientific official announced the enrollment of the first patients in the OPTIMIZE randomized controlled clinical trial. Read More

FDA grants expanded labelling approval of Boston Scientific’s PFA system


The US Food and Drug Administration (FDA) has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse pulsed field ablation (PFA) system. The approval marks a ... Read More

Boston Scientific Corp (BSX) Secures FDA Labeling Expansion for FARAPULSE Pulsed Field Ablation (PFA) System


Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks. On July 7, Boston Scientific (NYSE:BSX) saw its shares rise as TD Cowen reaffirmed its Buy rating and $115 ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus